PJSC Farmak pharmaceutical company will invest UAH 230 million in the development of projects in 2017, Farmak CEO Augustin Dubnicka has said.
According to Dubnicka, at present the company uses and plans to use mainly own funds for the development of projects, although in the past the company used a certain amount of attracted resources.
He also said in the first half of 2017 Farmak’s revenues increased by 23% YoY.
In 2017 the company expects to receive profit in the amount of about UAH 6.3 billion.
PJSC Farmak (Kyiv) is the largest pharmaceutical company in Ukraine. The ultimate beneficiary of the company is Filia Zhebrivska. (Interfax-Ukraine/Business World Magazine)